10-Q quarterly report · filed Oct 28, 2026

GE HealthCare (GEHC) Q3 2026 10-Q Quarterly Report

Short answer

GE HealthCare (GEHC) filed its Q3 2026 10-Q quarterly report on Oct 28, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $5.5B (up 7.2% year over year) with net income of $614M.

Q3 2026 key financials · XBRL

Revenue
$5.5B
+7.2% YoY · +4.2% QoQ
Net income
$614M
+37.7% YoY · +9.4% QoQ
Operating margin
14.6%
Gross margin
40.3%
EPS (diluted)
$1.36
+40.2% YoY · +10.6% QoQ

Source: XBRL data from the GE HealthCare (GEHC) Q3 2026 10-Q on SEC EDGAR. USD.

GE HealthCare Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $5,513M, up 7.2% YoY from $5,143M, organic growth 6.2%
  • Operating margin 14.6% vs 12.7% YoY, net margin 11.1% vs 8.7%
  • Best segment PDx: revenue $846M, up 13.0%; worst PCS: nine-month revenue $2,171M, down 4.0%
  • Operating cash flow $1,365M through nine months, up from $937M; $2,293M acquisition spending
  • Tariffs reduced Q3 operating income by $53M; management expects continued material impacts if tariffs persist at current levels

Risk Factors

  • No material changes to risk factors disclosed in the December 31, 2025 Form 10-K
  • Significant carried-forward risks remain unchanged from the latest annual filing

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other GE HealthCare quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.